AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26867559 — intervention group
Group type: COMPARATOR
Intervention: Unstructured practice (n = 10)
Number of subjects: 20
Study 23566045 — intervention group
Group type: EXPERIMENTAL
Intervention: Custom-fit mouthguards
Number of subjects: 40
Study 22354147 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihypertensive therapy for 13 months
Number of subjects: 103
Study 22354147 — intervention group
Group type: COMPARATOR
Intervention: Baseline measurements
Number of subjects: 103
Study 19997019 — intervention group
Group type: EXPERIMENTAL
Intervention: Fat-free milk (MILK)
Number of subjects: 20
Study 19997019 — intervention group
Group type: COMPARATOR
Intervention: Isoenergetic carbohydrate (CON)
Number of subjects: 20
Study 19005405 — intervention group
Group type: EXPERIMENTAL
Intervention: Basiliximab
Number of subjects: 82
Study 19005405 — intervention group
Group type: EXPERIMENTAL
Intervention: Basiliximab with MMF
Number of subjects: 82
Study 19005405 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study 19391530 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined acupuncture and Chinese herb group (n=32)
Number of subjects: 63
Study 19391530 — intervention group
Group type: COMPARATOR
Intervention: Simple Chinese herb group (n=31)
Number of subjects: 63
Study 15898474 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional Communication Training (FCT) plus punishment
Number of subjects: 2
Study 15898474 — intervention group
Group type: COMPARATOR
Intervention: Functional Communication Training (FCT)
Number of subjects: 2
Study 15898474 — intervention group
Group type: EXPERIMENTAL
Intervention: Preference evaluation for FCT with punishment
Number of subjects: 2
Study 11182531 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium treatment (acute administration for 7 days)
Number of subjects: 11
Study 11182531 — intervention group
Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 11
Study 9135307 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA
Number of subjects: 29
Study 9135307 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% amethocaine gel
Number of subjects: 29
Study 9135307 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 7963202 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine (modal dose 300 mg/day)
Number of subjects: 25
Study 7963202 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 3681312 — intervention group
Group type: EXPERIMENTAL
Intervention: terodiline
Number of subjects: 25
Study 30865529 — intervention group
Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass (RYGB)
Number of subjects: 150
Study 30865529 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleeve gastrectomy (SG)
Number of subjects: 150
Study 29226809 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (14,000 IU weekly)
Number of subjects: 47
Study 29226809 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study 29226809 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 47
Study 26385358 — intervention group
Group type: EXPERIMENTAL
Intervention: Guide to Action Care Home fall prevention intervention
Number of subjects: 145
Study 26385358 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 145
Study 24257813 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 384
Study 24257813 — intervention group
Group type: EXPERIMENTAL
Intervention: Nortriptyline
Number of subjects: 384
Study 24257813 — intervention group
Group type: EXPERIMENTAL
Intervention: CYP450 genotypes
Number of subjects: 384
Study 24257813 — intervention group
Group type: EXPERIMENTAL
Intervention: CYP450 genotype and antidepressant serum concentration
Number of subjects: 384
Study 24257813 — intervention group
Group type: EXPERIMENTAL
Intervention: Differences in antidepressant serum concentrations
Number of subjects: 384
Study 22534049 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary autologous freshly isolated bone marrow cells transplantation (BMCs‐Tx)
Number of subjects: 12
Study 22534049 — intervention group
Group type: COMPARATOR
Intervention: Control group (no cell therapy)
Number of subjects: 12
Study 19875426 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored care plans for practices and patients with reviews every four months
Number of subjects: 903
Study 17224574 — intervention group
Group type: EXPERIMENTAL
Intervention: Recovery from moderate disability (mRS 3) after recurrent ischemic stroke
Number of subjects: 345
Study 17224574 — intervention group
Group type: EXPERIMENTAL
Intervention: Recovery from severe disability (mRS 4) after recurrent ischemic stroke
Number of subjects: 345
Study 17224574 — intervention group
Group type: EXPERIMENTAL
Intervention: Recovery from very severe disability (mRS 5) after recurrent ischemic stroke
Number of subjects: 345
Study 17224574 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall recovery from disability after recurrent ischemic stroke
Number of subjects: 345
Study 17224574 — intervention group
Group type: EXPERIMENTAL
Intervention: Time to recovery from moderate disability (mRS 3)
Number of subjects: 345
Study 17224574 — intervention group
Group type: EXPERIMENTAL
Intervention: Time to recovery from severe disability (mRS 4)
Number of subjects: 345
Study 17224574 — intervention group
Group type: EXPERIMENTAL
Intervention: Mortality rate among disabled patients after recurrent ischemic stroke
Number of subjects: 345
Study 17224574 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictors of recovery from disability after recurrent ischemic stroke
Number of subjects: 345
Study 14980334 — intervention group
Group type: EXPERIMENTAL
Intervention: Droperidol 2.5 mg i.v.
Number of subjects: 96
Study 14980334 — intervention group
Group type: COMPARATOR
Intervention: Prochlorperazine 10 mg i.v.
Number of subjects: 96
Study 11207051 — intervention group
Group type: COMPARATOR
Intervention: Wide local excision
Number of subjects: 116
Study 11207051 — intervention group
Group type: COMPARATOR
Intervention: Excision plus radiotherapy
Number of subjects: 116
Study 11207051 — intervention group
Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 116
Study 9390984 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic exercise (cycling on an ergometer at 50% maximal oxygen consumption for 30 min/day, 5 days/wk, for two consecutive menstrual cycles)
Number of subjects: 16
Study 9390984 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic exercise
Number of subjects: 16
Study 9390984 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute strenuous exercise
Number of subjects: 16
Study 9390984 — intervention group
Group type: EXPERIMENTAL
Intervention: Deconditioning (after three menstrual cycles of no exercise)
Number of subjects: 16
Study 8177971 — intervention group
Group type: EXPERIMENTAL
Intervention: Easyhaler (MDPI)
Number of subjects: 21
Study 8177971 — intervention group
Group type: COMPARATOR
Intervention: Conventional metered dose inhaler (MDI)
Number of subjects: 21
Study 8177971 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 21
Study 2444132 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg/kg propofol (Disoprivan)
Number of subjects: 82
Study 2444132 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg/kg methohexital (Brevimytal)
Number of subjects: 82
Study 2444132 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.4 microgram fentanyl + 0.07 mg/kg droperidol (Thalamonal)
Number of subjects: 82
Study 2444132 — intervention group
Group type: EXPERIMENTAL
Intervention: Premedication with fentanyl
Number of subjects: 82
Study 2444132 — intervention group
Group type: COMPARATOR
Intervention: Comparative value from 60 examinations
Number of subjects: 82
Study 29032402 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.12% CHX + 0.2% NaF
Number of subjects: 32
Study 29032402 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.12% CHX
Number of subjects: 32
Study 29032402 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% NaF
Number of subjects: 32
Study 29032402 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 27453037 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mL isotonic drink
Number of subjects: 4576
Study 27453037 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mL water
Number of subjects: 4576
Study 27453037 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle tensing exercises
Number of subjects: 4576
Study 27453037 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotonic drink
Number of subjects: 4576
Study 27453037 — intervention group
Group type: COMPARATOR
Intervention: Advice to drink (control arm)
Number of subjects: 4576
Study 24102515 — intervention group
Group type: EXPERIMENTAL
Intervention: Group psychodynamic psychotherapy
Number of subjects: 28
Study 24102515 — intervention group
Group type: COMPARATOR
Intervention: Psycho-educational workshops (comparative group)
Number of subjects: 28
Study 23678501 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation intentions (II) group
Number of subjects: 291
Study 23678501 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-efficacy (SE) group
Number of subjects: 291
Study 23678501 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of implementation intentions and self-efficacy (II+SE) group
Number of subjects: 291
Study 23678501 — intervention group
Group type: COMPARATOR
Intervention: Control group (receiving written information on nutrition)
Number of subjects: 291
Study 20829257 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser-assisted liposuction (Smartly MPX laser, Cynosure, Inc.)
Number of subjects: 10
Study 20829257 — intervention group
Group type: COMPARATOR
Intervention: Liposuction alone
Number of subjects: 10
Study 18721244 — intervention group
Group type: EXPERIMENTAL
Intervention: Entecavir 0.5 mg/day
Number of subjects: 245
Study 18721244 — intervention group
Group type: COMPARATOR
Intervention: Lamivudine 100 mg/day
Number of subjects: 245
Study 18721244 — intervention group
Group type: EXPERIMENTAL
Intervention: Entecavir 1 mg/day
Number of subjects: 245
Study 17081466 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-suction drain
Number of subjects: 100
Study 17081466 — intervention group
Group type: COMPARATOR
Intervention: No drain
Number of subjects: 100
Study 12131216 — intervention group
Group type: EXPERIMENTAL
Intervention: HIVIGLOB 50 mg/kg
Number of subjects: 31
Study 12131216 — intervention group
Group type: EXPERIMENTAL
Intervention: HIVIGLOB 200 mg/kg
Number of subjects: 31
Study 12131216 — intervention group
Group type: EXPERIMENTAL
Intervention: HIVIGLOB 400 mg/kg
Number of subjects: 31
Study 10079418 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation after myocardial infarction
Number of subjects: 201
Study 10079418 — intervention group
Group type: COMPARATOR
Intervention: Usual care after myocardial infarction
Number of subjects: 201
Study 10079418 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation after identifying a recreational physical activity goal
Number of subjects: 201
Study 10079418 — intervention group
Group type: COMPARATOR
Intervention: Usual care after identifying a recreational physical activity goal
Number of subjects: 201
Study 7673302 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagenase ointment with polymyxin B sulfate/bacitracin powder
Number of subjects: 79
Study 7673302 — intervention group
Group type: COMPARATOR
Intervention: Silver sulfadiazine cream (1%)
Number of subjects: 79
Study 1981681 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine 5 mg twice daily for 4 weeks, then increased to 10 mg twice daily for another 4 weeks, followed by open-label felodipine 5-15 mg twice daily for 1 year.
Number of subjects: 103
Study 1981681 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide 25 mg once daily for 4 weeks, then increased to 50 mg once daily for another 4 weeks.
Number of subjects: 103
Study 7376786 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 g GABA (single dose)
Number of subjects: 19
Study 7376786 — intervention group
Group type: EXPERIMENTAL
Intervention: 18 g GABA (daily for 4 days)
Number of subjects: 19
Study 7376786 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 31779665 — intervention group
Group type: EXPERIMENTAL
Intervention: Subscapularis peel (SP)
Number of subjects: 21
Study 31779665 — intervention group
Group type: EXPERIMENTAL
Intervention: Lesser tuberosity osteotomy (LTO)
Number of subjects: 21
Study 31779665 — intervention group
Group type: COMPARATOR
Intervention: Standard subscapularis tenotomy (ST)
Number of subjects: 21
Study 28279661 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic balance training (10 weeks, 4 times per week)
Number of subjects: 40
Study 28279661 — intervention group
Group type: COMPARATOR
Intervention: Nonintervention group
Number of subjects: 40
Study 28279661 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic balance training
Number of subjects: 40
Study 25940075 — intervention group
Group type: EXPERIMENTAL
Intervention: Seattle Heart Failure Model (SHFM) + Peak Oxygen Consumption
Number of subjects: 2152
Study 25940075 — intervention group
Group type: EXPERIMENTAL
Intervention: Seattle Heart Failure Model (SHFM) + Expired Volume per Unit Time/Volume of Carbon Dioxide Slope
Number of subjects: 2152
Study 25940075 — intervention group
Group type: EXPERIMENTAL
Intervention: Seattle Heart Failure Model (SHFM) + 6-Minute Walk Distance (6MWD)
Number of subjects: 2152
Study 25940075 — intervention group
Group type: EXPERIMENTAL
Intervention: Seattle Heart Failure Model (SHFM) + Cardiopulmonary Exercise Duration
Number of subjects: 2152
Study 25940075 — intervention group
Group type: COMPARATOR
Intervention: Seattle Heart Failure Model (SHFM) alone
Number of subjects: 2152
Study 24369771 — intervention group
Group type: EXPERIMENTAL
Intervention: DECISION + 2
Number of subjects: 270
Study 24369771 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 270
Study 21266204 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin treatment
Number of subjects: 107
Study 21266204 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study 19651504 — intervention group
Group type: EXPERIMENTAL
Intervention: Genuair inhaler
Number of subjects: 48
Study 19651504 — intervention group
Group type: COMPARATOR
Intervention: HandiHaler A
Number of subjects: 48
Study 19651504 — intervention group
Group type: COMPARATOR
Intervention: HandiHaler B
Number of subjects: 48
Study 17000096 — intervention group
Group type: EXPERIMENTAL
Intervention: Bronchodilators (5 mg salbutamol plus 500 microg ipratropium bromide nebulisation)
Number of subjects: 28
Study 17000096 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen therapy (without bronchodilators)
Number of subjects: 28
Study 17000096 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of oxygen and bronchodilators
Number of subjects: 28
Study 17000096 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo/air)
Number of subjects: 28
Study 15087613 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil (target concentration, 80 ng/ml)
Number of subjects: 8
Study 11414374 — intervention group
Group type: EXPERIMENTAL
Intervention: Critical norms
Number of subjects: 0
Study 11414374 — intervention group
Group type: COMPARATOR
Intervention: Consensus norms
Number of subjects: 0
Study 11414374 — intervention group
Group type: EXPERIMENTAL
Intervention: Group norm manipulation
Number of subjects: 0
Study 9789907 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine fumarate treatment
Number of subjects: 10
Study 9789907 — intervention group
Group type: COMPARATOR
Intervention: Matched controls (n = 12)
Number of subjects: 10
Study 7626567 — intervention group
Group type: EXPERIMENTAL
Intervention: NEI Scheimpflug densitometry
Number of subjects: 55
Study 7626567 — intervention group
Group type: COMPARATOR
Intervention: Normal control group
Number of subjects: 55
Study 7626567 — intervention group
Group type: EXPERIMENTAL
Intervention: LOCS II clinical grading
Number of subjects: 55
Study 7626567 — intervention group
Group type: COMPARATOR
Intervention: Normal control group (LOCS II)
Number of subjects: 55
Study 7626567 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual acuity
Number of subjects: 55
Study 2924519 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual Analogue Scale (VAS)
Number of subjects: 10
Study 2924519 — intervention group
Group type: EXPERIMENTAL
Intervention: Borg Scale
Number of subjects: 10
Study 2924519 — intervention group
Group type: COMPARATOR
Intervention: Both scales (VAS and Borg)
Number of subjects: 10
Study 307810 — intervention group
Group type: EXPERIMENTAL
Intervention: High intensity TNS near the painful joint
Number of subjects: 0
Study 307810 — intervention group
Group type: EXPERIMENTAL
Intervention: Low intensity TNS
Number of subjects: 0
Study 307810 — intervention group
Group type: EXPERIMENTAL
Intervention: TNS applied at a remote site
Number of subjects: 0
Study 30465374 — intervention group
Group type: EXPERIMENTAL
Intervention: Succinylcholine 1mg (Group A)
Number of subjects: 60
Study 30465374 — intervention group
Group type: EXPERIMENTAL
Intervention: Succinylcholine (Group B)
Number of subjects: 60
Study 30465374 — intervention group
Group type: EXPERIMENTAL
Intervention: Succinylcholine (Group C)
Number of subjects: 60
Study 26435375 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard therapy arm of the ACCORD trial
Number of subjects: 4685
Study 24780946 — intervention group
Group type: COMPARATOR
Intervention: Hypolipidic diet (group D)
Number of subjects: 191
Study 24780946 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypolipidic diet and phyto-supplement (group E)
Number of subjects: 191
Study 22492367 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily consumption of hazelnuts, chocolate, and potato chips (∼1100 kJ/d) for 12 weeks
Number of subjects: 118
Study 22492367 — intervention group
Group type: COMPARATOR
Intervention: Control group (no additional food)
Number of subjects: 118
Study 22492367 — intervention group
Group type: EXPERIMENTAL
Intervention: All snack food groups including control
Number of subjects: 118
Study 22492367 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline SSS
Number of subjects: 118
Study 20671100 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) 3 times per week for 4 weeks
Number of subjects: 30
Study 20671100 — intervention group
Group type: COMPARATOR
Intervention: No treatment (standard of care)
Number of subjects: 30
Study 19195326 — intervention group
Group type: EXPERIMENTAL
Intervention: Elvitegravir/r (150/100 mg once daily) plus etravirine (200 mg twice daily)
Number of subjects: 34
Study 19195326 — intervention group
Group type: COMPARATOR
Intervention: Elvitegravir/r alone
Number of subjects: 34
Study 19195326 — intervention group
Group type: EXPERIMENTAL
Intervention: Elvitegravir/r plus etravirine
Number of subjects: 34
Study 15741590 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Negotiation Interview (BNI) performed by emergency practitioners (EPs)
Number of subjects: 58
Study 12969695 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone therapy (estradiol, 2 mg p.o., plus norethisterone acetate, 1 mg)
Number of subjects: 90
Study 12969695 — intervention group
Group type: COMPARATOR
Intervention: Alendronate (10 mg)
Number of subjects: 90
Study 10596203 — intervention group
Group type: EXPERIMENTAL
Intervention: Balanced anaesthetic techniques with fentanyl and halothane, isoflurane and enflurane
Number of subjects: 40
Study 10596203 — intervention group
Group type: COMPARATOR
Intervention: Total intravenous anaesthesia with fentanyl and midazolam
Number of subjects: 40
Study 8540776 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid tryptophan depletion
Number of subjects: 10
Study 8540776 — intervention group
Group type: COMPARATOR
Intervention: Sham control session
Number of subjects: 10
Study 2065688 — intervention group
Group type: EXPERIMENTAL
Intervention: Piroximone
Number of subjects: 12
Study 2065688 — intervention group
Group type: EXPERIMENTAL
Intervention: Dobutamine
Number of subjects: 12
Study 2065688 — intervention group
Group type: COMPARATOR
Intervention: Nitroprusside
Number of subjects: 12
Study 6414682 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination chemotherapy program (specifics not provided)
Number of subjects: 142
Study 3970673 — intervention group
Group type: EXPERIMENTAL
Intervention: Endarterectomized superficial femoral artery (ESFA) patch angioplasty
Number of subjects: 86
Study 3970673 — intervention group
Group type: COMPARATOR
Intervention: Vein patch
Number of subjects: 86
Study 31882008 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted walking (RAW)
Number of subjects: 12
Study 31882008 — intervention group
Group type: COMPARATOR
Intervention: Unassisted walking (UAW)
Number of subjects: 12
Study 28730849 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill training plus normal gait re-education
Number of subjects: 77
Study 28730849 — intervention group
Group type: COMPARATOR
Intervention: Normal gait re-education only (control)
Number of subjects: 77
Study 26909493 — intervention group
Group type: EXPERIMENTAL
Intervention: PMEA-coated circuits
Number of subjects: 20
Study 26909493 — intervention group
Group type: COMPARATOR
Intervention: Heparin-coated circuits
Number of subjects: 20
Study 25244402 — intervention group
Group type: EXPERIMENTAL
Intervention: Gatifloxacin 0.5%
Number of subjects: 1437
Study 25244402 — intervention group
Group type: COMPARATOR
Intervention: Vehicle treatment
Number of subjects: 1437
Study 22993919 — intervention group
Group type: EXPERIMENTAL
Intervention: Hopaten acid (40 mg/kg per day)
Number of subjects: 40
Study 22993919 — intervention group
Group type: COMPARATOR
Intervention: Propofol-fentanyl total intravenous anesthesia (TIVA) without hopaten acid
Number of subjects: 40
Study 20036427 — intervention group
Group type: COMPARATOR
Intervention: 30 mg tranylcypromine
Number of subjects: 36
Study 20036427 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg tranylcypromine
Number of subjects: 36
Study 17624978 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) plus referral to Gamblers Anonymous (GA)
Number of subjects: 127
Study 17624978 — intervention group
Group type: COMPARATOR
Intervention: Gamblers Anonymous (GA) referral alone
Number of subjects: 127
Study 15184959 — intervention group
Group type: EXPERIMENTAL
Intervention: SLP-C (customised corneal-polarisation compensation)
Number of subjects: 51
Study 15184959 — intervention group
Group type: EXPERIMENTAL
Intervention: SLP-F (fixed-angle corneal-polarisation compensation)
Number of subjects: 51
Study 12833248 — intervention group
Group type: EXPERIMENTAL
Intervention: Isokinetic muscle-strengthening exercise
Number of subjects: 132